Signup Crypto ETF Stocks News

Energy Management Systems Market Skyrockets to $105.2 Billion by 2031 | CAGR of 11.4% | Exclusive Report by The Insight Partners

US & Canada, April 02, 2025 ( GLOBE NEWSWIRE ) -- According to a new comprehensive report from The Insight Partners, "the global Energy Management Systems Market Size and Forecast ( 2021 - 2031 ) , Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Component ( ...

Source: www.benzinga.com
April 02, 2025 | 10:54:27
Category: News

YieldMax™ ETFs Announces Distributions on FIAT ( 127.21% ) , CVNY ( 100.49% ) , ULTY ( 77.62% ) , CONY ( 73.33% ) , YMAX ( 68.44% ) and Others

CHICAGO and MILWAUKEE and NEW YORK, April 02, 2025 ( GLOBE NEWSWIRE ) -- YieldMax™ today announced distributions for the YieldMax™ Weekly Payers and Group C ETFs listed in the table below. Performance data quoted represents past performance and is no guarantee of future results.

Source: www.benzinga.com
April 02, 2025 | 10:55:00
Category: News

AMC Expands Premium Movie Experience With IMAX Laser Upgrades In Landmark Deal - Imax ( NYSE:IMAX )

AMC will upgrade and expand IMAX with Laser to 180+ locations. The deal marks the largest U.S. IMAX agreement since 2018. The 'Trade of the Day' is now live. Get a high-probability setup with clear entry and exit points right here. AMC Entertainment Holdings Inc.

Source: www.benzinga.com
April 02, 2025 | 10:55:40
Category: News

Generation Bio to Present at the Needham 24th Annual Virtual Healthcare Conference

CAMBRIDGE, Mass., April 02, 2025 ( GLOBE NEWSWIRE ) -- Generation Bio Co. ( Nasdaq:GBIO ) , a biotechnology company working to change what's possible for people living with T cell-driven autoimmune diseases, announced that Geoff McDonough, M.D., president and chief executive officer, will ...

Source: www.globenewswire.com
April 02, 2025 | 10:59:00
Category: News

Nurix Licenses a Drug Discovery Program to Sanofi Targeting a Novel Transcription Factor for Autoimmune Diseases - Nurix Therapeutics ( NASDAQ:NRIX )

The undisclosed target is a central regulator of inflammation that is distinct from the previously disclosed STAT6 program Nurix DEL-AI drug discovery engine generated a drug discovery program to this previously undruggable target

Source: www.benzinga.com
April 02, 2025 | 11:00:00
Category: News

Nayax Announces Acquisition of Inepro Pay - Nayax ( NASDAQ:NYAX )

HERZLIYA, Israel, April 02, 2025 ( GLOBE NEWSWIRE ) -- Nayax Ltd. NYAXNYAX ) , a global commerce enablement and payments platform designed to help merchants scale their business by simplifying payments and maximizing loyalty, today announced the acquisition of Inepro Pay, a subsidiary of Inepro ...

Source: www.benzinga.com
April 02, 2025 | 11:00:00
Category: News

Tilray Shifts Cultivation of its Flagship Canadian Cannabis Brand and Strain, Good Supply Jean Guy, to Masson-Angers Facility in Québec - Tilray Brands ( NASDAQ:TLRY )

MASSON-ANGERS, Quebec, April 02, 2025 ( GLOBE NEWSWIRE ) -- Tilray Brands, Inc., company ( "Tilray" ) TLRYTLRY, a global lifestyle and consumer packaged goods company at the forefront of beverage, cannabis and wellness industries, and a leader in the Québec cannabis market, has officially ...

Source: www.benzinga.com
April 02, 2025 | 11:00:00
Category: News

Tonix Pharmaceuticals to Present at the 2025 Jones Trading Healthcare and Innovation Conference - Tonix Pharmaceuticals ( NASDAQ:TNXP )

CHATHAM, N.J., April 02, 2025 ( GLOBE NEWSWIRE ) -- Tonix Pharmaceuticals Holding Corp.

Source: www.benzinga.com
April 02, 2025 | 11:00:00
Category: News

Aura Biosciences Announces Appointment of Teresa Bitetti to Board of Directors

BOSTON, April 02, 2025 ( GLOBE NEWSWIRE ) -- Aura Biosciences, Inc. ( NASDAQ: AURA ) , a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ function, today announced the appointment of Teresa Bitetti, President of the Global Oncology ...

Source: www.globenewswire.com
April 02, 2025 | 11:00:00
Category: News

Autolus Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference - Autolus Therapeutics ( NASDAQ:AUTL )

LONDON, April 02, 2025 ( GLOBE NEWSWIRE ) -- Autolus Therapeutics plc AUTL, an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announces that the Company will participate in the 24th Annual Needham Virtual ...

Source: www.benzinga.com
April 02, 2025 | 11:00:00
Category: News

© Natavest 2025 - 2026